RemovedRisk Factors
generations of our existing products, our revenue could decline and our business, financial condition, and results of operations would be negatively affected.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
manner, we may have excess or obsolete inventory which we would have to reserve or write-down, and our gross margins would be adversely affected.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. We have identified material weaknesses in our internal control over financial reporting.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
We did not adequately design and maintain an effective risk assessment process at a sufficient precision level to identify risks of material misstatement in our consolidated financial statements. Specifically, the implementation of controls was not sufficient to respond to risks of material misstatement to financial reporting, including a lack of effectively designed controls over segregation of duties, particularly over the preparation and review of journal entries and account reconciliations.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
This material weakness could result in a misstatement of substantially all of the financial statement accounts and disclosures that would result in a material misstatement to our annual or interim consolidated financial statements that would not be prevented or detected.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
We did not design and maintain effective information technology (“IT”) general controls for information systems that are relevant to the preparation of its financial statements. Specifically, we did not design and maintain: (i) program change management controls to ensure that program and data changes are identified, tested, authorized, and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and to adequately restrict user and privileged access to appropriate personnel; (iii) computer operations controls to ensure that processing and transfer of data, and data backups and recovery are monitored; and (iv) program development controls to ensure that new software development is tested, authorized, and implemented appropriately.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
These IT deficiencies did not result in a material misstatement to our consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, we have determined these deficiencies in the aggregate constitute a material weakness.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
We began taking steps to remediate these material weaknesses through the implementation of business process and IT general controls in 2024. We have reviewed and are continuing to review business processes and IT processes and design and implement internal controls consistent with the principles of the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) framework to address the risks of material misstatement. Such activities include designing and implementing new business processes, enhancing information and communication processes, assessing risk, improvements to control documentation, enhancements to segregation of duties and access rights, and deployment of new IT systems and system functionalities as necessary. We are in the process of establishing a risk assessment process, including a monitoring function over internal control over financial reporting, including internal audit, to evaluate and enhance internal controls consistent with the COSO framework and the requirements of a public company. We further plan to implement and operate an appropriate set of IT general controls covering all financially significant systems, which includes controls covering security administration, segregation of duties, computer operations, system implementations, change management, complementary user controls for hosted systems, oversight activities for significant third-party vendors and others. In order to maintain and improve the effectiveness of our internal control over financial reporting as a public company, and once our material weaknesses have been remediated, we anticipate that we will continue to expend significant resources, including accounting-related costs and significant management oversight. Our current controls and any new controls that we develop may become inadequate because of changes in conditions in our business.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
We are not currently required to comply with the SEC rules that implement Section 404 of the Sarbanes- Oxley Act and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. As a public company, we are required to provide an annual management report on the effectiveness of our internal control over financial reporting commencing with our second annual report on Form 10-K. Our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until we are no longer considered an emerging growth company. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could harm our business and could cause a decline in the trading price of our common stock.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
Our business could be adversely affected by health crises in regions where we operate or otherwise do business. For example, the policies and regulations implemented in response to the outbreak of COVID-19 had a significant impact, both directly and indirectly, on businesses and commerce and the global supply chain for semiconductors. Although restrictions have generally been lifted, additional indirect effects such as supply shortages continue to impact segments of the global economy. Other global health concerns could also result in social, economic, and labor instability in the countries in which we or the third parties with whom we engage operate. The conditions caused by the COVID-19 pandemic and its aftermath as well as macroeconomic conditions have caused diminished liquidity and credit availability, declines in customer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability, and any future health crisis may have a similar impact.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
We are an emerging growth company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedRisk Factors
We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years or the earlier of, (i) the last day of the fiscal year in which we have total annual gross revenue of $1.235 billion or more, (ii) the date on which we have issued more than $1.0 billion in non-convertible debt during the previous three years, or (iii) the date on which we are deemed to be a large accelerated filer under the rules of the SEC. Investors may find our securities less attractive because we rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities, and the trading prices of our securities may be more volatile.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RewordedRisk Factors
These events, should they Should a cybersecurity incident or data breach occur, it could disrupt our business and result in, among other things, unfavorable publicity, damage to our reputation, loss of our trade secrets and other competitive information, litigation by affected parties and parties, possible financial obligations for liabilities and damages related to the theft or misuse of such any personal or confidential information, significant remediation costs, disruption of key business operations, and significant diversion of our resources, legal notifications and disclosures, as well as fines and other sanctions resulting from any related breaches of data privacy laws and regulations (such as the CCPA), any of which could have a material adverse effect on our business, profitability, and financial condition. resources.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
(iii) any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our second amended and restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine (collectively, the “Delaware Forum Provision”).
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
Any failure, or perceived failure, by us to comply with applicable data protection or other laws laws, or with regulatory obligations or industry standards in our customer contracts, could result in damage to our reputation, proceedings, or actions against us by governmental entities or others, subject us to significant fines, penalties, judgments, and negative publicity, require us to change our business practices, practices as well as increase the costs and complexity of compliance, and could have a material adverse effect on our business, financial condition, and results of operations. compliance.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
This legislation As enacted, the EU AI Act imposes significant obligations on providers and deployers of high risk artificial intelligence systems, AI systems and general purpose AI models and encourages providers and deployers of artificial intelligence systems to account for EU ethical principles in their development when developing and use of these systems. using AI technology.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we are unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable or fail to operate properly, we may not be able to secure adequate alternatives in a timely manner or at all, and our ability to offer our products and remain competitive in our market would be harmed.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we or any of our partners experience significant delays in a future transition or fail to efficiently implement a transition, we could experience reduced manufacturing yields, delays in product deliveries, and increased expenses, all of which could harm our relationships with our customers and our results of operations.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
If future pandemics, epidemics or other global health crises have a substantial impact on the productivity of our employees and partners, or a continued substantial impact on the materially impair our ability of to operate our employees to execute responsibilities, business or a continued and substantial impact on the our customers’ ability of our customers to purchase our products, our results of operations, operations and overall financial performance may be harmed.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
Some of the software used within our products, as well as that of some of our customers, may be derived from and/or incorporate so-called “open source” software that is generally made available to the public by its authors and/or other third parties under open source licenses, which in some instances may subject us to certain unfavorable conditions, including requirements that we offer our proprietary software, which incorporates or links to such open source software, for no cost or that we make such proprietary software publicly available for free.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
We cannot predict or estimate the amount or timing of these additional costs that we will continue to incur as a public company or company, and the specific timing resulting strain on management resources could adversely affect our results of such costs. operations and financial condition.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
In the past many Public health crises may result in cities, counties, states, and even countries have previously imposed or may impose imposing a wide range of restrictions on the physical movement of our employees, partners, and customers to limit the spread of COVID-19, customers, including physical distancing, travel bans and restrictions, closure of non-essential business, quarantines, work-from-home directives, and shelter-in-place orders.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
Significant resources will be required to design, develop, test and maintain our products to help ensure that artificial intelligence AI is implemented and deployed in accordance with applicable law and regulation and in a socially responsible manner intended to comply with applicable laws and to minimize any real or perceived unintended harmful impacts. regulations and mitigate foreseeable risks.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedRisk Factors
Although the governments of certain countries, including the United States, have taken actions to make their countries more attractive for chip manufacturing operations, there can be no assurances that the current geographic concentration of chip manufacturing will be meaningfully changed in the near term or at all.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Further, we continue to devote resources to protect our systems and data from unauthorized access or misuse, and we will likely be required to expend greater resources in the future.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Moreover, these rules and regulations have increased, and will continue to increase, our legal and financial compliance costs and make some certain activities more time-consuming and costly.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
AddedMD&A
(2) Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
AddedMD&A
(2) Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
AddedMD&A
Years Ended December 31, 2025 2024 (in thousands) Net cash provided by operating activities $ 319,306 $136,676 Net cash used in investing activities $ (241,469) $(757,568) Net cash provided by financing activities $ 9,803 $655,838
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
AddedMD&A
We account for the warrants issued to a customer as consideration payable as we did not receive a distinct good or service in exchange for the warrants. The shares underlying the warrants vest upon the achievement of specified tranches of global payments by the customer and its affiliates. As it becomes probable that the performance-based vesting conditions underlying the warrants will be achieved and the related revenue is recognized, we recognize the related grant date fair value of the warrants as a reduction of revenue for each sales transaction in proportion to total expected cumulative sales volume resulting in achievement of the vesting conditions. For more information, see Note 10 - Common Stock Warrants in the Notes to the Consolidated Financial Statements set forth in Part II, Item 8 of this Annual Report on Form 10-K.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
AddedMD&A
We allocate the fair value of the purchase consideration of a business acquisition to tangible and intangible assets acquired, including in-process research and development (“IPR&D”), and liabilities assumed based upon their estimated fair values at the acquisition date. The excess of the fair value of purchase consideration over the fair values of assets acquired and liabilities assumed is recognized as goodwill. Our valuation of acquired assets and assumed liabilities requires significant estimates, especially with respect to intangible assets. The valuation of intangible assets, in particular, requires that we use valuation techniques such as the income approach. The income approach includes the use of a discounted cash flow model, which includes discounted cash flow scenarios and requires the following significant estimates: future expected revenue, expected average selling unit price, obsolescence curve and technology life, and discount rates. Although we believe the assumptions and estimates we have made are reasonable, they are based in part on historical experience, market conditions and information obtained from management of the acquired companies, and are inherently uncertain. Unanticipated events and circumstances may occur, which could affect the accuracy or validity of such assumptions, estimates or actual results.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RemovedMD&A
On March 22, 2024, we completed our initial public offering (the “IPO”) of 22,770,000 shares of our common stock, par value $0.0001 per share (our “Common Stock”), at a price to the public of $36.00 per share, which included 19,758,903 shares of Common Stock sold by us, inclusive of 2,970,000 shares sold by us pursuant to the full exercise of the underwriters’ over-allotment option, as well as 3,011,097 shares of Common Stock sold by certain of our existing stockholders. We received net proceeds of $672.2 million, after deducting underwriting discounts and commissions of $39.1 million, and we did not receive any proceeds from the sale of our common stock by our existing shareholders in the IPO. In connection with the IPO, we recognized and paid deferred offering costs of $6.2 million.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
Where an arrangement includes multiple performance obligations, the transaction price is allocated to each performance obligation on a relative standalone selling price (“SSP”) basis. We determine the SSP based on an observable standalone selling price when it is available, as well as other factors, including the price charged to customers and our overall pricing objectives, while maximizing observable inputs.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
Accounts receivable are recorded when the customer has been billed or the right to consideration is unconditional. We record deferred revenue when we have received consideration, or an amount of consideration is due from the customer, and we have a future obligation to transfer products or services. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
We sell the majority of our products to distributors at a fixed list price. Distributors are authorized to resell our products to customers at a range of individually negotiated price points based on a variety of factors, including customer, product, quantity, geography, and competitive differentiation. The majority of our distributors’ resales are priced at a discount from list price (the original purchase price). After the resale transaction is completed, we issue credit memos to the distributor for the price adjustments.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
Revenue is recognized net of taxes collected, which are subsequently remitted to governmental authorities. Consideration payable includes cash amounts that we pay, or expect to pay, to a customer, and is included in accrued expenses and other current liabilities. Consideration payable also includes credits or other items. We account for consideration payable to a customer as a reduction of the transaction price, and therefore, of revenue, unless the payment to the customer is in exchange for a distinct good or service that the customer transfers to us.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
•Fair value of common stock – Prior to our IPO, we estimated the fair value of common stock, see Common Stock Valuations below. Post to our IPO, the fair value of common stock for purposes of options is the fair value of the
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
underlying common stock on the date of grant and for ESPP purchases is based on the stock price on the first date of the respective offering period.
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
Prior to our IPO, the fair value of the common stock underlying our stock-based awards has historically been determined by our board of directors, with input from management and contemporaneous third-party valuations. We believe that our board of directors has the relevant experience and expertise to determine the fair value of our common stock. Given the absence of a public trading market of our common stock, and in accordance with the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation, our board of directors exercised reasonable judgment and considered numerous objective and subjective factors to determine the best estimate of the fair value of our common stock at each grant date. These factors include:
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
•the results of contemporaneous valuations performed at periodic intervals by a third-party valuation firm;
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
•the prices, rights, preferences, and privileges of our redeemable convertible preferred stock relative to those of our common stock;
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
•the prices of our redeemable convertible preferred stock and common stock sold to investors in arms- length transactions;
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RemovedMD&A
•our actual operating and financial performance and estimated trends and prospects for our future performance;
Read it in 10-K Feb 14, 2025 at sec.govopen_in_new
RewordedMD&A
Total Our revenue increased $280.5 million, or 242%, for the year ended December 31, 2024 2025, increased by 115% compared to the year ended December 31, 2023, same period in 2024, primarily due to a 217% an increase in overall unit shipments driven by higher demand for our Aries Aries, Scorpio, and Taurus products, as well as higher overall average selling prices resulting from an increased mix of hardware modules and Scorpio products.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
Years Ended December 31, 2025 2024 2023 (in thousands, except percentages) GAAP operating loss income (loss) $ 173,423 $ (116,066) $ (29,497) Stock-based compensation expense upon IPO (1) — 88,873 — Stock-based compensation expense 160,033 145,715 10,679 Acquisition-related costs (2) 950 — Employer payroll tax related to stock-based compensation from IPO (2) (3) — 1,072 — Non-GAAP operating income (loss) $ 334,406 $ 119,594 $ (18,818) GAAP operating margin 20.3 % (29.3) % (25.5) % Stock-based compensation expense upon IPO (1) — 22.4 — Stock-based compensation expense 18.8 36.8 9.2 Acquisition-related costs 0.1 — Employer payroll tax related to stock-based compensation from IPO (2) (3) — 0.3 — Non-GAAP operating margin 39.2 % 30.2 % (16.3) %
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
A discussion regarding our financial condition and results of operations for the year ended December 31, 2023 2024 compared to the year ended December 31, 2022 2023 can be found in the section titled part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our final prospectus, dated March 19, 2024 and Annual Report on Form 10-K filed with the SEC on March 21, 2024 pursuant to Rule 424(b) of the Securities Act. February 14, 2025.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
The increase was primarily due to an increase in revenue was also attributable to overall unit shipments driven by higher demand for our Aries, Scorpio, and Taurus products, as well as higher overall average selling prices resulting from an increased mix of hardware modules. modules and Scorpio products.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
Years Ended December 31, 2025 2024 2023 (in thousands) GAAP net loss income (loss) $ 219,134 $ (83,421) $ (26,257) Stock-based compensation expense upon IPO (1) — 88,873 — Stock-based compensation expense (2) 160,033 145,715 10,679 Acquisition-related costs 950 — Employer payroll tax related to stock-based compensation from IPO (2) (3) — 1,072 — Income tax effect (3) (4) (49,102) (8,910) — Non-GAAP net income (loss) $ 331,015 $ 143,329 $ (15,578)
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
Our gross profit has been, and may in the future be, primarily influenced by several factors, including sales volumes, pricing of our products and services, changes in product costs, contract manufacturing supplier pricing, amortization of capitalized production equipment, personnel costs, shipping and logistics costs, and inventory write-downs.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
The change in income tax (benefit) provision was p primarily due to a significant the increase in non-cash stock-based compensation tax deductions post our IPO, and U.S. research and development credits, deductions, partially offset by an increase the decrease in taxable income, and the foreign-derived intangible income deduction.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
Research and development expenses consist of personnel-related costs incurred in performing research and development activities and include including salaries, non-cash stock-based compensation expense, employee benefits, bonuses, pre-production engineering mask costs, software license and cloud hosting services costs, prototype wafer, packaging and test costs, and allocated shared expenses.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
Years Ended December 31, 2025 2024 2023 (in thousands, except percentages) GAAP gross profit $ 645,261 $ 302,699 $ 79,827 Stock-based compensation expense upon IPO (1) — 516 — Stock-based compensation expense 1,123 329 24 Non-GAAP gross profit $ 646,384 $ 303,544 $ 79,851 GAAP gross margin 75.7 % 76.4 % 68.9 % Stock-based compensation expense upon IPO (1) — 0.1 — Stock-based compensation expense 0.1 0.1 Non-GAAP gross margin 75.8 % 76.6 % 69.0 %
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
RSUs granted post IPO includes only service-based vesting conditions and stock-based compensation expense will be are recognized equal to the grant date fair value on a straight-line basis over the four-year requisite service period of the awards.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in revenue was also attributable primarily due to higher overall average selling prices unit shipments and a shift in product mix, resulting from an increased mix of hardware modules. modules and Scorpio products.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
RewordedMD&A
We have presented non-GAAP operating income (loss) and non-GAAP operating margin because we consider non-GAAP operating income (loss) to be a them useful metric metrics for investors and other users of our financial information in evaluating our operating performance as it excludes the impact of non-cash stock-based compensation expense expense, acquisition-related costs, and employer payroll taxes related to the time-based vesting and net settlement of RSUs in connection with our IPO, charges a charge that can vary from period to period or are one time charges for reasons that are unrelated to our core operating performance.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new
Quiet changesMD&A
Interest income primarily consists of interest income earned on our short-term investments included in cash and cash equivalents and marketable securities.
Read it in 10-K Feb 20, 2026 at sec.govopen_in_new